These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 6114514)
21. Rate dependent stimulation of insulin and glucagon but not gastrin and somatostatin release during the intestinal phase of a meal. Schusdziarra V; Dangel G; Henrichs I; Klier M; Pfeiffer EF Horm Metab Res; 1982 Apr; 14(4):169-71. PubMed ID: 6123480 [TBL] [Abstract][Full Text] [Related]
22. Basal and meal-induced somatostatin-like immunoreactivity in healthy subjects and in IDDM and totally pancreatectomized patients. Effects of acute blood glucose normalization. Gutniak M; Grill V; Wiechel KL; Efendić S Diabetes; 1987 Jul; 36(7):802-7. PubMed ID: 2884157 [TBL] [Abstract][Full Text] [Related]
23. Effects of soy polysaccharide on postprandial plasma glucose, insulin, glucagon, pancreatic polypeptide, somatostatin, and triglyceride in obese diabetic patients. Tsai AC; Vinik AI; Lasichak A; Lo GS Am J Clin Nutr; 1987 Mar; 45(3):596-601. PubMed ID: 2881482 [TBL] [Abstract][Full Text] [Related]
24. Effect of bombesin on plasma insulin, pancreatic glucagon, and gut glucagon in man. Bruzzone R; Tamburrano G; Lala A; Mauceri M; Annibale B; Severi C; de Magistris L; Leonetti F; Delle Fave G J Clin Endocrinol Metab; 1983 Apr; 56(4):643-7. PubMed ID: 6339534 [TBL] [Abstract][Full Text] [Related]
25. Effect of vagotomy and atropine on plasma somatostatin response to a meal in conscious dogs. Woussen-Colle MC; Lalieu C; Simoens C; De Graef J Regul Pept; 1988 May; 21(1-2):29-36. PubMed ID: 2899334 [TBL] [Abstract][Full Text] [Related]
30. Fluctuations in basal levels and effects of altered nutrition on plasma somatostatin. Hansen BC; Vinik A; Jen KL; Schielke GP Am J Physiol; 1982 Sep; 243(3):R289-95. PubMed ID: 6126125 [TBL] [Abstract][Full Text] [Related]
31. Contribution of the pancreas to circulating somatostatin-like immunoreactivity in the normal dog. Taborsky GJ; Ensinck JW J Clin Invest; 1984 Jan; 73(1):216-23. PubMed ID: 6140271 [TBL] [Abstract][Full Text] [Related]
32. Effects of substance P and other peptides on the release of somatostatin, insulin, and glucagon in vitro. Hermansen K Endocrinology; 1980 Jul; 107(1):256-61. PubMed ID: 6155261 [TBL] [Abstract][Full Text] [Related]
33. Pancreatic and gastric release of somatostatinlike immunoreactivity during intestinal phase of a meal. Schusdziarra V; Rouiller D; Pietri A; Harris V; Zyznar E; Conlon JM; Unger RH Am J Physiol; 1979 Dec; 237(6):E555-60. PubMed ID: 517653 [TBL] [Abstract][Full Text] [Related]
34. Low-dose infusion of somatostatin in man--no effect upon intestinal calcium absorption but a fall in blood insulin. Rümenapf G; Hanisch E; Schwille PO Exp Clin Endocrinol; 1986 Aug; 87(3):306-12. PubMed ID: 2877894 [TBL] [Abstract][Full Text] [Related]
36. Evidence of a paracrine role for pancreatic somatostatin in vivo. Taborsky GJ Am J Physiol; 1983 Dec; 245(6):E598-603. PubMed ID: 6140853 [TBL] [Abstract][Full Text] [Related]
37. Sympathetic nerve stimulation versus pancreatic norepinephrine infusion in the dog: 2). Effects on basal release of somatostatin and pancreatic polypeptide. Ahrén B; Veith RC; Paquette TL; Taborsky GJ Endocrinology; 1987 Jul; 121(1):332-9. PubMed ID: 2885175 [TBL] [Abstract][Full Text] [Related]
38. Plasma somatostatin-like immunoreactivity and somatostatin-28 levels in obese men. Peracchi M; Carola F; Cavagnini F; Benti R; Bareggi B; Baccalaro G; Basilisco G J Endocrinol Invest; 1998 Jan; 21(1):20-3. PubMed ID: 9633018 [TBL] [Abstract][Full Text] [Related]